United Therapeutics Corporation

Unither Neurosciences, Inc.

Beta Air, LLC

United Technology Corporation

Worldspace Corporation

William Harvey Research Limited

Utasia Inc.

Martine A Rothblatt

Robert G Shorr

Lewis J Rubin

Herman Wiegman

Michael David Bentley

Xuan Zhao

Steven Willard Arms

Kyle B Clark

Michael Wade

Riley Clinton Griffin

Robert Roscigno

Gilles Cloutier

Augustus Brightman

James W Crow

Roger Corder

Shelmer D Blackburn, Jr

Adrian P L Smith

Timothy W Higgenbottam

John Vane

Delphine Dominique Marthe Lees

A computing device for enhancing communications is disclosed. The computing device includes a memory configured to store data, a video camera configured to receive video input data, and a microphone configured to receive audio input data. The computing device also includes a processor that is configured to analyze the received video input data, the received audio input data, and the data stored in the memory. The computing device further includes a visual display device that is configured to output a visual display based on the processor analysis, and a speaker output device that is configured to output an audio signal based on the processor analysis.

Computing device for enhancing communications

A selectively deployable heated propulsor system which may be integrated into vehicles, airplanes, or any other machinery configured for flight. The system includes a structural feature that includes a mounted propulsor including a rotor and a motor mechanically coupled to the rotor allowing the rotor to rotate when in an activated mode. The mounted propulsor includes a chamber configured to support a first configuration where the propulsor and the rotor are stowed and heated in an enclosed environment, and a second configuration where the rotor is deployed.

Selectively deployable heated propulsor system

One embodiment relates to a method of treating pulmonary hypertension based upon co-administering to a subject in need thereof a pharmaceutically effective amount of an oral therapeutic agent for treating pulmonary hypertension and a pharmaceutically effective amount of an inhaled therapeutic agent for treating pulmonary hypertension. The benefit of the co-administration of these agents is to eliminate or reduce one or more side effects associated with mono-therapy of either agent, as well as one or more side effects associated with other administration routes such as subcutaneous or intravenous administration.

Treatment for pulmonary hypertension

Sequences in human preproendothelin-1 mRNA are described against which antisense oligonucleotides can be used to inhibit the synthesis of endothelin-1. This inhibition of endothelin-1 synthesis may be used to treat diseases where excess production of endothelin-1 is an underlying cause of the symptoms.

Inhibitors of endothelin-1 synthesis

The present invention is directed to a pharmaceutical composition containing a cancer-treating effective amount of a class of prostacyclin derivatives, and a pharmaceutically acceptable carrier, and to kits and methods of employing the same for the treatment of cancer.

Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer

Prostaglandin and analogs thereof which include protective groups attached to at least one site which are pharmaceutically acceptable and which are capable of slowing the metabolic rate of the active groups for administration to a warm blooded animal for the treatment of congestive heart failure.

Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure

A system for providing global and portable Internet access to low cost user terminals comprises an Internet service provider gateway and a broadcast station for providing multimedia information from the gateway to the user terminals via a direct radio broadcast geostationary satellite. User terminals each comprise a direct radio broadcast receiver and a transceiver for communicating with a low earth orbit (LEO) satellite. User terminals transmit Internet access requests, menu selections and other backhaul signals to the gateway via the transceiver. The broadcast station transmits information requested by the user from the gateway to a specific user terminal by providing identification codes in the broadcast programs. The user terminals are programmable to receive all broadcast programs but to demodulate and demultiplex only those broadcast channels addressed to the user terminal. Internet access is available simultaneously with reception of satellite direct broadcasts of audio programs.

System for providing global portable internet access using low earth

An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene) -13,14-dihydro-prostaglandin F.sub.1.

Use of

Growing community of inventors

Satellite Beach, FL, United States of America

Martine A Rothblatt